## Abstract ## Objectives/Hypothesis: To determine the effect of comorbidity on 1βyear postβtreatment quality of life (QOL) in patients with head and neck squamous cell cancer (HNSCC). ## Methods: One hundred twentyβfive previously untreated HNSCC patients participated in longitudinal QOL analys
Changes in quality-of-life scores in a population of patients treated for squamous cell carcinoma of the head and neck
β Scribed by Erin M. McDonough; Mark A. Varvares; Frank R. Dunphy; Teresa Dunleavy; Cherie H. Dunphy; James H. Boyd
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 605 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Background: Quality of life levels fluctuate depending on treatment type and at various points throughout treatment. In patients with advanced head and neck cancer, quality of life is thought to be treatment dependent. The purpose of this study is to compare levels of patients self-reported quality of life across treatment.
Patients and Methods: Preliminary data presented here are based on 24 patients enrolled so far in an experimental organpreservation protocol. The two treatment groups consist of one group treated with chemotherapy (paclitaxel and carboplatin) followed by radiation therapy and the second group which is treated with chemotherapy (paclitaxel and carboplatin) followed by surgery and postoperative radiation. Data is collected pretreatment and at uniform points throughout the course of treatment.
Results: Preliminary results suggest that quality of life is significantly higher in the nonsurgical group than in the surgical group at the last treatment point reported. Social distress/avoidance is also lower in the nonsurgical group. Because of the small number of patients represented in this study, results should be interpreted with caution and should be viewed as descriptive at this juncture.
π SIMILAR VOLUMES
Genomic instability in simple repeated sequences has been observed in several human cancers. We have analyzed 50 squamous cell carcinomas of the head and neck (SCCHN) and 5 pre-malignant severe dysplastic tissues from Indian patient populations for microsatellite instability in 18 different loci spr
## Abstract ## Background. Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage. Modalities for the neck are neck dissection and/or radiation therapy. In most cases, the neck is treated by the modality that seems more appropriate for the
## Abstract ## Objectives/Hypothesis: To identify factors associated with nonparticipation in longβterm qualityβofβlife (QOL) analysis in head and neck squamous cell cancer (HNSCC) patients. ## Study Design: Restrospective analysis of prospectively collected data. ## Methods: Two hundred sixty
Gm, A2m, and Km allotypic markers were examined in 40 Caucasian patients with squamous cell carcinomas of the head and neck. Serum IgA levels, the A2m(l) allotypic marker, and antibodies against IgAl, A2m(l), and A2m(2) were measured quantitatively. The frequency of Km(1) was found to be significant